Latest News
Here you can find all the latest news from the MRC CTU at UCL.
International collaboration sheds light on how aspirin prevents cancer
A research collaboration led from the MRC CTU at UCL suggests that the anti-cancer effects of aspirin are mediated through suppression of platelet activation.
UCL Joins WHO Global Clinical Trials Forum
As a new member of the WHO’s Global Clinical Trial Forum, the MRC CTU at UCL will be bringing cutting-edge trial design, conduct and analysis to strengthen research systems worldwide.
Shorter, more intensive treatment for TB meningitis in children is not as effective as the standard treatment
SURE trial results presented today at the Union conference did not show that a shorter, intensive treatment for TB meningitis in children is as good as the standard treatment. Adding aspirin also showed no benefit.
New methodology guidance on inverse probability of censoring weighting in clinical trials
Our methodologists published guidance on how to apply IPCW effectively and how to stabilise IPCW weights to improve precision, without overlooking potential bias.
Our tuberculosis research at The Union World Conference on Lung Health 2025
Our researchers and collaborators will present the latest results of our TB clinical trials, including new findings from the SURE trial.